PuraPharm Corporation Limited announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was HKD 302.757 million compared to HKD 280.432 million a year ago. Net income was HKD 11.974 million compared to HKD 11.437 million a year ago. Basic earnings per share from continuing operations was HKD 0.0304 compared to HKD 0.0328 a year ago.